The Right Trials, Patients, and Places for Meaningful Oncology Research

Innovative research requires an ingenious mediation of patient and program needs. Worldwide excels in the essentials while taking a vanguard approach to the latest in preclinical science and study design.

TEAM BACKGROUND MAKES A DIFFERENCE

Many of our oncology team members have spent time conducting research or clinical care themselves, giving them an edge in overcoming the operational and patient-centered challenges that often plague trials conducted in this space. From preclinical and dose escalation expertise to regulatory approval, we are just the right size to offer accessible, nimble attention and a bevy of the industry’s top talent. That’s why Worldwide is rated a top performer for staff, delivery, budget and loyalty across phase I-III CRO services by Industry Standard Research.

JANA KNEZEVIC

SENIOR ONCOLOGY PROJECT MANAGER

Jana has more than a decade of experience in oncology therapeutic development, providing clinical trial management expertise with a strong grounding in regulatory affairs. With a background in CROs, sponsor companies, and academia, her knowledge spans the entire breadth of the clinical development space. Her personal dedication to therapeutic advancement in the service of cancer patients drives her commitment to supporting sponsors in their development goals.

GARY FISHBEIN

VICE PRESIDENT, THERAPEUTIC AREA LEAD, ONCOLOGY

Gary Fishbein, MD, MPH, Vice President, Therapeutic Area Lead, Oncology has more than two decades of experience in oncology drug development within biotech, pharma, and CRO. He is a board-certified oncologist with experience across all phase of development in various tumor types such as breast cancer, Hodgkin and non-Hodgkin lymphomas, cutaneous T-cell lymphoma, head and neck cancer, non-small cell lung cancer, prostate cancer, adult leukemia, gastrointestinal cancers, renal cell cancer, gynecologic malignancies, giant cell tumor of tendon sheath, multiple myeloma, and glioblastoma multiforme, to name a few.

He engages with staff to ensure successful integration of feasibility assessments, trial designs, clinical operations, and regulatory processes. A member of the American Society of Clinical Oncology, he has lectured, authored, and co-authored on such indications as T-cell lymphoma, adolescent melanoma, pancreatic cancer, metastatic breast cancer, systemic amyloidosis, acute myeloid leukemia, Hodgkin lymphoma, and hepatocellular carcinoma.

CLARE WALLIS

SENIOR VICE PRESIDENT, PROJECT MANAGEMENT

Clare has held responsibilities at all levels of drug development including data manager, clinical research associate, global project management lead, and more. Clare’s experience is invaluable in guiding and supporting operational teams in achieving project success. From project planning, execution, oversight, to patient recruitment, team mentoring, and sponsor engagement, Clare is well-versed in mitigating risks and creating a culture of effective communication among stakeholders and team members for optimal results.

LEANNE DRUMMOND

SENIOR DIRECTOR, PROJECT MANAGEMENT, ONCOLOGY AND RARE DISEASES

Leanne has more than 25 years of project management experience in CROs and the pharmaceutical industry, specializing in oncology studies. She is skilled in providing support and oversight to Worldwide’s large national and global project and program management teams. She mentors staff and assesses program metrics to ensure quality, time, and budget deliverables are met. She has supported all research stages, including CMC, pharmacology, toxicology, regulatory, and clinical studies phase I-IV, and has worked on more than 10 multi-indication development programs. Her therapeutic experience in oncology includes solid tumors, ovarian cancer, hematological malignancies, acute myeloid leukemia (requiring stem cell transplant, peripheral, and cord blood), breast cancer, and glioblastoma.

DANA F. DURST

SENIOR DIRECTOR, SITE ACTIVATION & REGULATORY THERAPEUTIC LEAD, ONCOLOGY

Dana F. Durst, Senior Director, Site Activation & Regulatory Therapeutic Lead, Oncology, at Worldwide Clinical Trials has more than 16 years of clinical research experience. Her experience ranges among a broad span of therapeutic areas including oncology, gene therapy, NASH, dermatology, ophthalmology, and cardiovascular studies extending from Phase I-IV. She has overseen all aspects of startup as well as maintenance activities in a variety of countries worldwide in both early and late phase trials, and with both small, agile clients and large clients.

  • expert image
  • expert image
  • expert image
  • expert image
  • expert image

Expertise You Can Rely On 

We’ve cultivated a tenured, talented team of experts to craft unique, resourceful solutions for each and every project. Forge a partnership that matters and let Worldwide Clinical Trials Oncology introduce you to the research experience you deserve.

Oncology Experience

  • Common Cancers
  • Advanced Solid Tumors
  • Breast Cancer
  • Cervical Cancer
  • Chemo Induced Anorexia or Cachexia
  • Colorectal Cancer
  • Endometrial Cancer
  • Melanoma
  • Myelodysplastic Syndrome
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Stomach Cancer
  • Tenosynovial Giant Cell Tumor
  • Rare Cancers
  • Acute Myeloid Leukemia (AML)
  • B-Cell Non-Hodgkin Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Gastrointestinal Stromal Tumor (GIST)
  • Glioblastoma Multiforme (GBM)
  • Hepatocellular Carcinoma
  • Idiopathic Thrombocytopenic Purpura
  • Triple-Negative Breast Cancer
  • Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

Our Dedicated Team